Furthermore, ovarian cancer patients with relatively high DLAT expressions presented relatively poor OS, PPS, and PFS (Figs. 3H–3I, Fig. S3F), while patients of gastric cancer with relatively high DLAT expressions showed relatively poor OS and PPS (Figs. 3J–3K). This evidence concerns the gene DLAT and ovarian carcinoma.